Last Received
funnyordie
Fri, 12 Dec 2025 16:26
china2
Fri, 12 Dec 2025 16:23
vanchina2
Fri, 12 Dec 2025 16:23
by
Fri, 12 Dec 2025 16:22
nbobby
Fri, 12 Dec 2025 16:19
bob
Fri, 12 Dec 2025 16:18
cb322c5
Fri, 12 Dec 2025 15:34
gp6dd
Fri, 12 Dec 2025 15:33
liamonnn
Fri, 12 Dec 2025 15:26
jonbobby
Fri, 12 Dec 2025 15:25
Newest Addresses
new_batch13
Thu, 11 Dec 2025 20:43
dsssdsdsd5s5d9999sdsdeee
Thu, 11 Dec 2025 20:18
shsks
Wed, 10 Dec 2025 14:17
infodsdsdsdsdsdsdsd
Mon, 08 Dec 2025 20:41
cnn
Thu, 27 Nov 2025 20:34
theverge
Wed, 26 Nov 2025 22:45
boxhero
Sun, 23 Nov 2025 17:25
dtlrs
Fri, 21 Nov 2025 00:02
dieratech
Wed, 19 Nov 2025 19:00
theoriginalunderground
Wed, 19 Nov 2025 15:03
Last Read
lumosity
Fri, 12 Dec 2025 16:26
gp6dd
Fri, 12 Dec 2025 16:26
cb322c5
Fri, 12 Dec 2025 16:26
funnyordie
Fri, 12 Dec 2025 16:26
liamont
Fri, 12 Dec 2025 16:26
gp6
Fri, 12 Dec 2025 16:26
nomailnn
Fri, 12 Dec 2025 16:25
jonbobby
Fri, 12 Dec 2025 16:25
bob
Fri, 12 Dec 2025 16:25
bby
Fri, 12 Dec 2025 16:24
Most Received
ail
128533
gp6
109239
jonbobby
83500
gp6dd
83306
bobby
63255
mydailymoment
59822
cb322c5
55727
vanchina2
55046
liamont
52671
funnyordie
51033
Available Messages
The following is a list of recent messages for lumosity. Select one to see the content. Messages are removed frequently. Check early. Check often.
Subject
Received
Introducing LumosityRx, an FDA-Cleared ADHD Treatment
Thu, 11 Dec 2025 19:14:25 GMT
☀️🧠 A fresh season, a fresh way to engage your brain
Tue, 09 Dec 2025 19:13:06 GMT
Selected Message
From: newsletter@...
To: [email protected]
Date: Thu, 11 Dec 2025 19:14:25 GMT
Subject: Introducing LumosityRx, an FDA-Cleared ADHD Treatment
To: [email protected]
Date: Thu, 11 Dec 2025 19:14:25 GMT
Subject: Introducing LumosityRx, an FDA-Cleared ADHD Treatment
- Plain Text
- HTML Content
- HTML Source
Plain Text
************************************************************
How Lumosity’s Science Inspired a New Kind of ADHD Treatment
************************************************************
I'm Dr. Bob Schafer, Head of Science at Lumosity. I'm excited to
introduce LumosityRx, an FDA-cleared, prescription digital
therapeutic for adults with ADHD.
***************
How We Got Here
***************
For nearly two decades, Lumosity has helped millions of people
train their brains with engaging, science-based games targeting
skills like Attention, Memory, Problem Solving, and more. From
the very beginning, Lumosity has been designed for healthy people
who want to challenge themselves and stay mentally active. But as
our understanding of the science deepened, we began to see even
broader possibilities.
Lumosity scientists and our academic collaborators have
published over 130 peer-reviewed research articles exploring the
mechanisms and effects of cognitive training. Those findings led
to an exciting question: could the same science and technology
that power Lumosity also help those facing clinically significant
challenges?
We decided to focus on adults with
Attention-Deficit/Hyperactivity Disorder (ADHD). It’s a
population with a clear need for more treatment options. While
stimulant medications can be highly effective for many, others
prefer to avoid medication or need additional support to manage
their symptoms. We wanted to build something different —
effective, accessible, safe, and engaging — by applying
Lumosity’s strengths in cognitive training and digital design.
That vision led to the development of LumosityRx.
**********************
Pivotal Clinical Trial
**********************
Using insights from Lumosity’s research, we selected thirteen
Lumosity games most relevant to the cognitive challenges
associated with ADHD, then built a new structured therapeutic
program based on them. This program was designed to guide
patients through a personalized, adaptive training regimen —
about 15 minutes per day — with built-in feedback and progress
tracking.
To evaluate LumosityRx, we conducted a pivotal randomized
controlled trial — the gold standard for clinical research —
involving 560 adults with ADHD. Participants used the treatment
program from LumosityRx or a control program over nine weeks. The
trial ran from May 2022 to March 2024 and was conducted across 13
independent clinical sites. The results were compelling:
* Statistically significant improvement in attention compared to
the control group. On average, their attention functioning
improved by 1.1 points compared to 0.3 points in the control
group, as measured by the TOVA®, a test used to measure selective
and sustained attention.
* Significant clinician-rated improvement on the Clinical Global
Impression–Improvement (CGI-I) scale, showing greater overall
ADHD improvement for patients using LumosityRx.
* Meaningful gains in quality of life. People using LumosityRx
reported improvements in their personal, day-to-day lives — like
how their ADHD impacts their emotional balance and feelings of
productivity.
* Excellent safety profile, with no serious side effects and less
than 1% of participants reporting any mild or moderate ones.
These clinical results were reviewed by the U.S. Food and Drug
Administration (FDA), which cleared LumosityRx as a prescription
digital therapeutic for adults with ADHD. Though the FDA
clearance applies only to LumosityRx, it also marks an important
milestone in our broader mission to make cognitive science
accessible and impactful. Please note that Lumosity - which is
designed for a healthy audience - has not been evaluated by the
FDA and is not intended to diagnose, treat, cure, or prevent any
disease or condition.
***********************
Why This Moment Matters
***********************
For us, the FDA clearance isn’t just a regulatory milestone.
It’s the fulfillment of a vision that’s been central to our work
from the beginning: that digital experiences, grounded in
rigorous science, can create new avenues for care.
LumosityRx is the start of a new chapter for our company. We’re
deeply grateful to the community that helped us grow, learn, and
push the boundaries of what cognitive training can achieve.
We can’t wait to share what comes next.
**************
Keep Exploring
**************
************************************************
About LumosityRx ( https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3jd8ug_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizskLnGl587oBhT2Z71FaYhKuiijeYNOLk8Po46c-2FSztuQjwYCig6FG6KgAdICEraGQQDmfSx2mLunOQl790gT0od1WhjI75NV06Phxe2eIm7Q-2B5xtW4AWthMSn08uM7zc2vZ1oCDiXQy-2FzGAuCea7d9w-3D-3D )
************************************************
****************************************************************
The Science Behind Lumosity ( https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C4qsOGrjElq7nZLFumepu1Wfyaa_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsa6AsR8LXi6x8J9GCEWj35F8J-2F2HFq2yBgt2RFSNj-2B08wIem3Xv-2FoPEsyh-2F5nmDomsbIh0q8mYzcLChH0dlAcTXl2vr7VysW-2F0m3EIev-2BqwKjk8pz3Q8ZHDpXR7kz8HLAnvu-2BEszdTPO8mUyYtBIhVw-3D-3D )
****************************************************************
LumosityRx was cleared by the FDA under the name “Prismira.”
Indications for Use: Prismira is a digital therapeutic indicated
to improve attention function in adults ages 22‐55 years old with
primarily inattentive or combined‐type Attention Deficit and
Hyperactivity Disorder (ADHD). Patients who engage with Prismira
demonstrate improvements in a digitally assessed measure of
sustained and selective attention, Test of Variables of Attention
(TOVA), and may not display benefits in typical behavioral
symptoms, such as hyperactivity. Prismira should be considered
for use as part of a therapeutic program that may include
clinician directed therapy, medication, and/or educational
programs, which further address symptoms of the disorder.
Limitations: Prismira may not be appropriate for users with
photo‐sensitive epilepsy, color blindness, or physical
limitations that restrict use of a mobile device. Always consult
with your healthcare provider before starting any new treatment.
This information does not replace professional medical advice,
diagnosis, or treatment.
Lumosity is not the same as LumosityRx: Please note that FDA
clearance applies to LumosityRx, not to Lumosity, which is
designed for a healthy audience. Lumosity has not been evaluated
by the FDA and is not intended to diagnose, treat, cure, or
prevent any disease or condition.
About
( https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ-2Fpz1McSU2uo4vE89DWkpRZ89F5WphUBXRr8CqzGNxbiezptkIc0GtKa9BY4DPz1sPwbKEuqZvoSPW13DNW2EErlDwkGCAA5XNk1ciSOgz6Rw-3D-3DhwK3_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsP9ftAkxqsZEjPp1r8y7wXSRRO6yZe5H4-2FtRczy6Pp0fyO-2ByPXQSiDTyc3AS6R8Uk6b-2Fzs2I-2Fl0-2FOgP-2B1FHGsG4VlgyGrY14Kljx-2BLgunuLw5eOTEWLP9A2ewCC3F2cL4yyrW2W-2BWPIpKGmZI0oA7Cw-3D-3D )
Help
( https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6u2QSZN5g1sm5TyDBmDvO-2Fq-2B6xBVV-2BTh27lMlVMQMtt4rV8k-2B-2F3tAV3mMg3EBuaU9A-3D-3DOfZw_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsAEiAZZTx0fJXVGGeNhfO3rDfHMX8LjHdQ2YZqRQGkTSRo5k6WzBHiYxubeYJ1K-2BPo07Myjnl-2BCtYsqnleW-2FkNUnS3n3MCNsKGV7JpDFyRZVHPhohLD0F43RG6MJDVonZpZsD-2Bz1MVU0c67zrg5M38Q-3D-3D )
Legal
( https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ-2BliB-2B2c15Z1aqyHa5o2LUJQIBnLQ5kkR5EH-2B1nEOrSYQlPBBVwPfcf-2BpE7McV85aK6Sw6lx36yCpOi7qXnD3ji4l2AzJ9hvpCOHE0tRkTN0vi1ZvgKO9jYVHvwnWubE2M-3D7PcV_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsQ3G0VPbQ76piYn3Yohqq81Itq6yOhRNBqRU71jLSF-2FSf9zb1bHkyB-2FGJJorlVemerpG046mjvScJFpO3-2Fphwc4pYAMi4PZLGq8P8UONnrRRcoXc6a3mDq4WW3Jz08C8d515uuFlLGMdulqFYYHT-2F-2BA-3D-3D )
Update (
https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ8XZSbgjoIjY-2By-2F-2B6U5-2FXYDo2b1AIA1wY7Ca-2FhKPS3n3oCAH5-2F99C0mtDVD7fidT76K6XizTgytQOER1GCy3CDnh-2F-2B05tIfkugdovGQlNiHodllAidx8EiW55RIwJq-2B6ZFMpv-2BSR-2Fxlo8GnOmXq8yaqeYiVd7scjF-2BetFSOrcW-2B7Vb6tA4iQcnpLSVFcMewiHL1uzQ0b4nuwDWXzd2wS4eFQo-2Fe3umdKBY1Qdo5WEE4fFKpdMkvvnqpEBgvTbjE964yYKmSQkuRgMftMsGBO7p7uPxD_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizs78H-2FmPBBTZedLechFgkCrrHu7cbmsmLuK4n3ZPzvilf-2FjOzTcOio9kIyfM4Q1VJAjldr0L8u8H4Tjvp7tJyzUN-2F54mRU8xaOkkW7C28blRurkYV-2BUI71WTK9X048R20ZLBd6f6UTQV987tcsOQU9EQ-3D-3D ) preferences for
[email protected] or unsubscribe (
https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6mcijAqjvcyx6liKorHQ8a-2FXbZ9wKxllOMk2N7dqrtpaRB8iAz-2B5pTNo67u13u-2B3k46YT9MDRvgqevIbdJ909O3vG0BlyJf6a7MaNrKfmet-2BZ7CCBmB8GP83zKIO3xajU9FAvhtfqlXwR21NCo3YERoMUs0xvSSQxadE-2FHSKEWaOdgYbvi2H1iRiZKtxYGalLPHrisCUSEawZHmpA86OOTq53W7vLjcP3j0-2FvV228qO44is9AJNm2ZfJ0CIMpOelBi5hRtVBHgKt0g84FhPUexENAriKrJ3AUbM-2FngGwg30dPg4pA-2B3VHUumJSiQmFKtWiQqdahGdI1bRP2M052NioK7v67sGnhDBErGU1nPHIUnr8xf-2BIO6VwXqjQ9Kc8umhGFJBizrYFyQ7vM0tXqGGZY3SN-2FJj7VSz-2F9zMc9gu9EvU7pDZOr4PNLrgF5i-2FLigYeY8CPxy8QxwlNwQiL7NVFR2jmHBSIG-2FitKZkIAzciYJ-2BermiZiCiY-2BLJf2QCht2i0uCpzrv3-2FvwzKZfBNpP8YxiE8JvYEJh0-2B63XLXgyi1NcI4u9MDtlxSREbiaNdjRdTtSQ1xX-2Fr0LsljaUIeTsJSSeejljYmxi-2FPOi2Pj7hac4YKdYKU5B79picYpkkY-2BYhoX9YENHY-2FFnlvOt0Qwjnmy-2Fb8-2BiYOW768b2-2Fgl-2Blnz5dHp_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsU0fOoSrBWOqN-2BSCIczKBHAFLDRSSvrHtfaQvGpwiEhOWbcuTno-2FVKDcUI4NsJmA9DsyjSHvjQAWluJC9fxLvvD2R0kEfuF3T-2F5IEcYv5Gh6JSPvDmqMTroYtJ3k47qAytvepMjl7JAlQUH8hhbSauA-3D-3D ).
© 2025 Lumos Labs, Inc. | 16 Maiden Lane, Suite 6,
San Francisco, CA 94108
HTML Content
HTML Source
<!DOCTYPE html>
<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" lang="en">
<head>
<title></title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<!--[if mso]>
<xml><w:WordDocument xmlns:w="urn:schemas-microsoft-com:office:word"><w:DontUseAdvancedTypographyReadingMail/></w:WordDocument>
<o:OfficeDocumentSettings><o:PixelsPerInch>96</o:PixelsPerInch><o:AllowPNG/></o:OfficeDocumentSettings></xml>
<![endif]--><!--[if !mso]><!--><link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,100;0,300;0,400;0,700;0,900;1,100;1,300;1,400;1,700;1,900" rel="stylesheet" type="text/css">
<!--<![endif]--><style>
*{box-sizing:border-box}body{margin:0;padding:0}a[x-apple-data-detectors]{color:inherit!important;text-decoration:inherit!important}#MessageViewBody a{color:inherit;text-decoration:none}p{line-height:inherit}.desktop_hide,.desktop_hide table{mso-hide:all;display:none;max-height:0;overflow:hidden}.image_block img+div{display:none}sub,sup{font-size:75%;line-height:0}#converted-body .list_block ol,#converted-body .list_block ul,.body [class~=x_list_block] ol,.body [class~=x_list_block] ul,u+.body .list_block ol,u+.body .list_block ul{padding-left:20px} @media (max-width:620px){.image_block div.fullWidth{max-width:100%!important}.mobile_hide,.row .side{display:none}.row-content{width:100%!important}.stack .column{width:100%;display:block}.mobile_hide{min-height:0;max-height:0;max-width:0;overflow:hidden;font-size:0}.desktop_hide,.desktop_hide table{display:table!important;max-height:none!important}.row-2 .column-1 .block-1.image_block .alignment div{margin:0 auto!important}.row-12 .column-1 .block-1.heading_block h1,.row-3 .column-1 .block-1.heading_block h1,.row-5 .column-1 .block-2.heading_block h1,.row-6 .column-1 .block-2.heading_block h1{font-size:26px!important}.row-10 .column-1 .block-2.paragraph_block td.pad>div,.row-12 .column-1 .block-2.paragraph_block td.pad>div,.row-4 .column-1 .block-1.paragraph_block td.pad>div,.row-5 .column-1 .block-3.paragraph_block td.pad>div,.row-6 .column-1 .block-3.paragraph_block td.pad>div{font-size:16px!important}.row-4 .column-1 .block-1.paragraph_block td.pad{padding:15px!important}.row-6 .column-1 .block-4.list_block ul,.row-9 .column-1 .block-2.list_block ul{font-size:16px!important;line-height:auto!important}.row-13 .column-1 .block-1.heading_block h1{font-size:22px!important}.row-15 .column-1 .block-1.heading_block h1,.row-17 .column-1 .block-1.heading_block h1{font-size:18px!important}.row-18 .column-1 .block-2.paragraph_block td.pad{padding:20px 15px 5px!important}.row-7 .column-1,.row-8 .column-1{padding:5px!important}.row-19 .column-1{padding:5px 10px!important}}
</style>
<!--[if mso ]><style>sup, sub { font-size: 100% !important; } sup { mso-text-raise:10% } sub { mso-text-raise:-10% }</style> <![endif]-->
</head>
<body class="body" style="margin:0;background-color:#fff;padding:0;-webkit-text-size-adjust:none;text-size-adjust:none"><img src="https://links.notifications.lumosity.com/wf/open?upn=u001.H-2FjGz6MnOOHZwiriS9k30RRln85Eo4zEepnIque-2BAd1w2xxwLo8EzyB6glivC8ZEbj9h-2FMRwyve4PPbzrG1lQp45CYzEXm3yKYMx7kQEKTieGiGPxTP4GzSRJsbdp26U6kkjuItKouRVetZ1ebmBts5Ontp8pb42-2Fv8iF5pp3MPfx-2FEUJzijD8REBneZEqIVK995tnh1j-2B3ol4TC2qVU-2FWuANLiVE-2FxtVj-2FT3q0ksleefkrVg0TX0jwBbW6Zc3RFhgQ-2FwC0yYzRTwlOY9gMdb9Dk11fqfo27TRIZE9vzCX0TiWF3lNdMVNdEbAGGKlgVtpbunOHT6OYuZv293ZBHIhbCSFEuWgeU4CzP01A9LwSMCrSXblR-2B8gYluqTT9RrcQdKHXZETgxMVC9bSE7Di8KY1dbzB-2F5cHTzfCUZV71gUWBx5XdXhF-2B3RJJrGuQ55H7yzxShJFpWmM7UMhpBWXBesv7S7GsjD8B9tU3AtX9kiKv7RWlA5RPk5nI7xrFAIZHc9mF4c2-2BIQUmkGVf5N9bUG7cNpEsXHkRfz73NnGQtKj4MNbGirNpQRSX9ggtzkKUmmyetOTSMvO1SVNNmSzER-2Brv85e0l-2Fe-2FCwT6zNMgM9-2FkyRuOQlZCMiNnjLjp95HAXkXvbGYuX8D4P-2FJiJzoVw904LWsmETyFDPUZkvvZoyBGr3jjlYczDDIAmjkgF7fjUbSr0DsMH8VmcLhI3scU9-2F1SVCP2qCoHga7H0w76h-2FnV5o9e4vDJm0iHO4JgzzHmTzuWhcYhl6oDbFkEjqFdg-3D-3D" alt="" width="1" height="1" border="0" style="height:1px !important;width:1px !important;border-width:0 !important;margin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 !important;padding-left:0 !important;"/><table class="nl-container" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td>
<table class="row row-1" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><div class="spacer_block block-1" style="height:40px;line-height:40px;font-size:1px"> </div></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-2" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="image_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:20px;width:100%;padding-right:0;padding-left:0"><div class="alignment" align="center"><div style="max-width:120px"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3jw-eM_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsXD9kQGzU8abmkboS-2FrFFmd57nJB-2FfnSRRRzxv5tRi5xo8pX4FPM8xkyeYs94-2FkrAPhVIBBDDGLbwLMsOeuy4ry7EFckXFHvqbC2LeoWKexve03m-2B2hrPh2-2BTfEOd8nI8ATbX6JVLRxzfKWNTZe4phg-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/6939260cf3bc45007031e7ad/original.png?1765352971" style="display:block;height:auto;border:0;width:100%" width="120" alt title height="auto"></a></div></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-3" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-left:15px;padding-right:15px;vertical-align:top"><table class="heading_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:20px;text-align:center;width:100%"><h1 style="margin:0;color:#111;direction:ltr;font-family:Georgia,Arial,Sans-serif;font-size:40px;font-weight:400;letter-spacing:normal;line-height:1.2;text-align:center;margin-top:0;margin-bottom:0;mso-line-height-alt:48px"><span class="tinyMce-placeholder" style="word-break: break-word;">How Lumosity’s Science Inspired a New Kind of ADHD Treatment</span></h1></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-4" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="paragraph_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-bottom:15px;padding-left:20px;padding-right:15px;padding-top:15px"><div style="color:#2a333c;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:29px"><p style="margin:0"><strong>I'm Dr. Bob Schafer, Head of Science at Lumosity.</strong> I'm excited to introduce LumosityRx, an FDA-cleared, prescription digital therapeutic for adults with ADHD.</p></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-5" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;padding-bottom:10px;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:15px;vertical-align:top">
<table class="divider_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center"><table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table></div></td></tr></table>
<table class="heading_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:30px;text-align:center;width:100%"><h1 style="margin:0;color:#000;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:28px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:34px"><span class="tinyMce-placeholder" style="word-break: break-word;">How We Got Here</span></h1></td></tr></table>
<table class="paragraph_block block-3" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-left:15px;padding-right:15px;padding-top:5px"><div style="color:#2a333c;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:29px">
<p style="margin:0;margin-bottom:0">
For nearly two decades, Lumosity has helped millions of people train their brains with engaging, science-based games targeting skills like Attention, Memory, Problem Solving, and more. From the very beginning, Lumosity has been designed for healthy people who want to challenge themselves and stay mentally active. But as our understanding of the science deepened, we began to see even broader possibilities.</p>
<p style="margin:0;margin-bottom:0"><br>
Lumosity scientists and our academic collaborators have published over 130 peer-reviewed research articles exploring the mechanisms and effects of cognitive training. Those findings led to an exciting question: <strong>could the same science and technology that power Lumosity also help those facing clinically significant challenges?</strong></p>
<p style="margin:0"><br>
We decided to focus on adults with Attention-Deficit/Hyperactivity Disorder (ADHD). It’s a population with a clear need for more treatment options. While stimulant medications can be highly effective for many, others prefer to avoid medication or need additional support to manage their symptoms. We wanted to build something different — effective, accessible, safe, and engaging — by applying Lumosity’s strengths in cognitive training and digital design. That vision led to the development of LumosityRx.
</p>
</div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-6" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;vertical-align:top">
<table class="divider_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center">
<table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table>
</div></td></tr></table>
<table class="heading_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:30px;text-align:center;width:100%"><h1 style="margin:0;color:#2a333c;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:28px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:34px">Pivotal Clinical Trial</h1></td></tr></table>
<table class="paragraph_block block-3" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-bottom:5px;padding-left:15px;padding-right:15px"><div style="color:#2a333c;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:29px">
<p style="margin:0;margin-bottom:0">
Using insights from Lumosity’s research, we selected thirteen Lumosity games most relevant to the cognitive challenges associated with ADHD, then built a new structured therapeutic program based on them. This program was designed to guide patients through a personalized, adaptive training regimen — about 15 minutes per day — with built-in feedback and progress tracking.</p>
<p style="margin:0"><br>
To evaluate LumosityRx, we conducted a pivotal randomized controlled trial — the gold standard for clinical research — involving 560 adults with ADHD. Participants used the treatment program from LumosityRx or a control program over nine weeks. The trial ran from May 2022 to March 2024 and was conducted across 13 independent clinical sites. The results were compelling:</p>
</div></td></tr></table>
<table class="list_block block-4" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word;color:#101b24;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.4;text-align:left;mso-line-height-alt:25px"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:10px"><div style="margin-left:-20px"><ul start="1" style="margin-top:0;margin-bottom:0;list-style-type:revert"><li style="Margin:0 0 1px 0">
<strong>Statistically significant improvement in attention</strong> compared to the control group. On average, their attention functioning improved by 1.1 points compared to 0.3 points in the control group, as measured by the TOVA®, a test used to measure selective and sustained attention.</li></ul></div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-7" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top;border-radius:0"><table class="image_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:15px;padding-top:15px;width:100%;padding-right:0;padding-left:0"><div class="alignment" align="center"><div class="fullWidth" style="max-width:480px">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3j4OCV_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsDKF-2BTFsOSWEbfnZWfz9bFL7L17VVcamCeHRiseSSoosomY4AwOU5bFSwa3b9DJNUqPhq2DscaoQs54VzCzUAcx-2B-2Bve7JNkCB-2FLEnygicckz0WDSqF35Lw-2FN47bSS-2BFNtNducDBzQuKkkKgJLkbgYCA-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/692d83bd262ae700649b061b/original.png?1764590524" style="display:block;height:auto;border:0;width:100%" width="480" alt title height="auto"></a>
</div></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-8" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top;border-radius:0"><table class="image_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:15px;padding-top:15px;width:100%;padding-right:0;padding-left:0"><div class="alignment" align="center"><div class="fullWidth" style="max-width:480px">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3jDN_s_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsqKgDw56Xp15lKgkO10plbH1XnebANMEWqtWcbmn02-2FfIcazrkXrNZfPNhzTCcoZSnV4jA6nR6fjiBgXuoS1RQHBe1fZmTp9fPgS2CJqaLBc6-2BlrPmNEGk3SAn3ybID4jh4jOQoWREtbynGIBS45AjQ-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/692d83cefd8886006385d2a3/original.png?1764590542" style="display:block;height:auto;border:0;width:100%" width="480" alt title height="auto"></a>
</div></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-9" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;vertical-align:top">
<div class="spacer_block block-1" style="height:20px;line-height:20px;font-size:1px"> </div>
<table class="list_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word;color:#101b24;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.4;text-align:left;mso-line-height-alt:25px"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:10px"><div style="margin-left:-20px"><ul start="1" style="margin-top:0;margin-bottom:0;list-style-type:revert">
<li style="Margin:0">
<strong>Significant clinician-rated improvement</strong> on the Clinical Global Impression–Improvement (CGI-I) scale, showing greater overall ADHD improvement for patients using LumosityRx.<div> </div>
</li>
<li style="Margin:0">
<strong>Meaningful gains in quality of life</strong>. People using LumosityRx reported improvements in their personal, day-to-day lives — like how their ADHD impacts their emotional balance and feelings of productivity.<div> </div>
</li>
<li style="Margin:0">
<strong>Excellent safety profile,</strong> with no serious side effects and less than 1% of participants reporting any mild or moderate ones.</li>
</ul></div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-10" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;vertical-align:top">
<div class="spacer_block block-1" style="height:20px;line-height:20px;font-size:1px"> </div>
<table class="paragraph_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:10px"><div style="color:#101b24;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:29px"><p style="margin:0">
These clinical results were reviewed by the U.S. Food and Drug Administration (FDA), which cleared LumosityRx as a prescription digital therapeutic for adults with ADHD. Though the FDA clearance applies only to LumosityRx, it also marks an important milestone in our broader mission to make cognitive science accessible and impactful. Please note that Lumosity - which is designed for a healthy audience - has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition.
</p></div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-11" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody>
<tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top">
<div class="spacer_block block-1" style="height:40px;line-height:40px;font-size:1px"> </div>
<table class="divider_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center"><table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table></div></td></tr></table>
</td></tr></tbody></table></td></tr>
</tbody></table>
<table class="row row-12" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;vertical-align:top">
<table class="heading_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:10px;text-align:center;width:100%"><h1 style="margin:0;color:#2e3c47;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:28px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:34px"><span class="tinyMce-placeholder" style="word-break: break-word;">Why This Moment Matters</span></h1></td></tr></table>
<table class="paragraph_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-bottom:5px;padding-left:15px;padding-right:15px"><div style="color:#2a333c;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:29px">
<p style="margin:0;margin-bottom:0">
For us, the FDA clearance isn’t just a regulatory milestone. It’s the fulfillment of a vision that’s been central to our work from the beginning: that digital experiences, grounded in rigorous science, can create new avenues for care.</p>
<p style="margin:0;margin-bottom:0"><br>LumosityRx is the start of a new chapter for our company. We’re deeply grateful to the community that helped us grow, learn, and push the boundaries of what cognitive training can achieve.</p>
<p style="margin:0"><br>
We can’t wait to share what comes next.</p>
</div></td></tr></table>
<table class="image_block block-3" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="width:100%;padding-right:0;padding-left:0"><div class="alignment" align="left"><div class="fullWidth" style="max-width:480px"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3je2Eo_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsjm1Q8BagF2kkK-2BG9YPeVV-2BG9rEg05SlI2Q-2BIN8ZawZZR6iZPaPJ6Eu427SokfW0vpLcxQbupQ2wwQc9gUHvgyATOm8leMH7oznvPEROjLtvj2WIx1PlW0QoLVoAOczJwR4HE9coapvmDQ1guAUa3Ug-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/69380c7548d8420063ff498a/original.png?1765280885" style="display:block;height:auto;border:0;width:100%" width="480" alt="Doctor Bob Schafer Signature" title="Doctor Bob Schafer Signature" height="auto"></a></div></div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-13" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="heading_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-left:15px;padding-right:15px;padding-top:20px;text-align:center;width:100%"><h1 style="margin:0;color:#2e3c47;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:20px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:24px">
<span class="tinyMce-placeholder" style="word-break: break-word;">Keep Exploring</span>
</h1></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-14" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="divider_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center"><table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-15" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr>
<td class="column column-1" width="83.33333333333333%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="heading_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-left:15px;padding-right:15px;padding-top:5px;text-align:center;width:100%"><h1 style="margin:0;color:#fd6533;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:22px">
<span class="tinyMce-placeholder" style="word-break: break-word;"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3jMx48_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizskYBzoYtURXeb2nySauEaDPOkuM3HQ-2BPJ-2BVFGHpr0vWzqKyqHw7Tgi9Jd726gNUh77FKT2j-2BIDKNUwjrCc1oau9txpZ0f1DjIDl3k-2FFky0AR4NB7cJD6IutZtlAYLH-2BUY34Ou90vAek0qaWpiJlcbSg-3D-3D" target="_blank" style="text-decoration: none; color: #FD6533;" data-mce-attribute-name-1 data-mce-attribute-value-1 data-mce-attributes-count="1" rel="noopener"><span class="mce-content-body mce-edit-focus" style="word-break: break-word; position: relative;" id="481899dd-ef01-4c5b-abc5-94d5729eec9c" data-position="140-0-0" data-qa="tinyeditor-root-element"><span class="tinyMce-placeholder" style="word-break: break-word;">About LumosityRx</span></span></a></span>
</h1></td></tr></table></td>
<td class="column column-2" width="16.666666666666668%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="image_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-right:10px;width:100%;padding-left:0"><div class="alignment" align="right"><div style="max-width:30px"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C6RhQCgLjr-2BOfcXQOykZI3jqrr-_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsUv-2FmZQ5ZDmbOt9SN6JvpXxe36dwb4ZPws2lT3-2BY8bus5gYCJUi-2Fca6DSbx4QSp4Itw4Imh062S3K9CDkiHgNsPik7XyyHk-2BGwx-2B0SI8SznOX4GBZPQ9rvipQO0uMn-2BVwT4Ale7k9D9sEL8TZpF9p3g-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/693929e743a689006364d03f/original.png?1765353959" style="display:block;height:auto;border:0;width:100%" width="30" alt title height="auto"></a></div></div></td></tr></table></td>
</tr></tbody></table></td></tr></tbody></table>
<table class="row row-16" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="divider_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center"><table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table></div></td></tr></table></td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-17" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tbody><tr><td><table class="row-content" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr>
<td class="column column-1" width="83.33333333333333%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="heading_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-left:15px;padding-right:15px;padding-top:5px;text-align:center;width:100%"><h1 style="margin:0;color:#fd6533;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:18px;font-weight:700;letter-spacing:normal;line-height:1.2;text-align:left;margin-top:0;margin-bottom:0;mso-line-height-alt:22px">
<span class="tinyMce-placeholder" style="word-break: break-word;"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C4qsOGrjElq7nZLFumepu1WLeDf_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsoY0NKqj-2FJWrVGNk86x0-2FIT-2F1wITq2E0VuQj15rVqXfr-2BpsBd7aexTX4O49w8lPcRtYRy3sdG3DJnUtPPK2ffxtuOUTGWrpDaUlIx6gAWhZH9jtPijFfKJWhanmR4vPdAfrsxHplGpGOYeNheg4zMSQ-3D-3D" target="_blank" style="text-decoration: none; color: #FD6533;" data-mce-attribute-name-1 data-mce-attribute-value-1 data-mce-attributes-count="1" rel="noopener"><span class="mce-content-body mce-edit-focus" style="word-break: break-word; position: relative;" id="9aac79e5-e806-4070-a880-59414082a6df" data-position="180-0-0" data-qa="tinyeditor-root-element"><span class="tinyMce-placeholder" style="word-break: break-word;">The Science Behind Lumosity</span></span></a></span>
</h1></td></tr></table></td>
<td class="column column-2" width="16.666666666666668%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top"><table class="image_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad" style="padding-right:10px;width:100%;padding-left:0"><div class="alignment" align="right"><div style="max-width:30px"><a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6hKEMdYNGZINIWNFivIR8C4qsOGrjElq7nZLFumepu1WmjHf_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsPRGjn4uVNae8dC3irY-2FUbksS6KMmfyEK-2BsFfRuKA3bZT-2FExlQcreywp2vDHgEzT4qrq2QOw5by-2B1rrIYf-2BNzreNkpZjkylW0l4ITeY19qt-2FV3oubvJNUukAPnr-2BX0wynIC-2BL6LI4LWXKGv9sSgxG-2BA-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/693929e743a689006364d03f/original.png?1765353959" style="display:block;height:auto;border:0;width:100%" width="30" alt title height="auto"></a></div></div></td></tr></table></td>
</tr></tbody></table></td></tr></tbody></table>
<table class="row row-18" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-top:5px;vertical-align:top">
<table class="divider_block block-1" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div class="alignment" align="center"><table border="0" cellpadding="0" cellspacing="0" role="presentation" width="100%" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="divider_inner" style="font-size:1px;line-height:1px;border-top:1px solid #e5e1dd"><span style="word-break: break-word;"> </span></td></tr></table></div></td></tr></table>
<table class="paragraph_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;word-break:break-word"><tr><td class="pad" style="padding-bottom:10px;padding-left:15px;padding-right:15px;padding-top:30px"><div style="color:#0e2337;direction:ltr;font-family:Lato,Arial,Sans-serif;font-size:14px;font-weight:400;letter-spacing:0;line-height:1.6;text-align:left;mso-line-height-alt:22px">
<p style="margin:0;margin-bottom:0">LumosityRx was cleared by the FDA under the name “Prismira.”</p>
<p style="margin:0;margin-bottom:0"><br>
Indications for Use: Prismira is a digital therapeutic indicated to improve attention function in adults ages 22‐55 years old with primarily inattentive or combined‐type Attention Deficit and Hyperactivity Disorder (ADHD). Patients who engage with Prismira demonstrate improvements in a digitally assessed measure of sustained and selective attention, Test of Variables of Attention (TOVA), and may not display benefits in typical behavioral symptoms, such as hyperactivity. Prismira should be considered for use as part of a therapeutic program that may include clinician directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.
</p>
<p style="margin:0;margin-bottom:0"><br>Limitations: Prismira may not be appropriate for users with photo‐sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device. Always consult with your healthcare provider before starting any new treatment. This information does not replace professional medical advice, diagnosis, or treatment.</p>
<p style="margin:0"><br>
Lumosity is not the same as LumosityRx: Please note that FDA clearance applies to LumosityRx, not to Lumosity, which is designed for a healthy audience. Lumosity has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition.</p>
</div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
<table class="row row-19" align="center" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff"><tbody><tr><td><table class="row-content stack" align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0;background-color:#fff;border-radius:0;color:#000;width:600px;margin:0 auto" width="600"><tbody><tr><td class="column column-1" width="100%" style="mso-table-lspace:0;mso-table-rspace:0;font-weight:400;text-align:left;padding-bottom:5px;padding-left:10px;padding-right:10px;padding-top:5px;vertical-align:top">
<div class="spacer_block block-1" style="height:30px;line-height:30px;font-size:1px"> </div>
<table class="html_block block-2" width="100%" border="0" cellpadding="0" cellspacing="0" role="presentation" style="mso-table-lspace:0;mso-table-rspace:0"><tr><td class="pad"><div style="font-family:Lato,Arial,Sans-serif;text-align:center" align="center">
<tr>
<td class="pt-10" style="padding-top: 10px;">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="py-30" style="border-top: 1px solid #f5f2f0; padding-top: 30px; padding-bottom: 30px;">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="column img mt-center" width="94" style="padding:0; margin:0; font-weight:normal; font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ-2Fpz1McSU2uo4vE89DWkpRZ89F5WphUBXRr8CqzGNxbiezptkIc0GtKa9BY4DPz1sPb4FwTWDvRY-2BfXZ3KbrZWUFPsI34Z392ohDxTPIG1S-2FA-3D-3DS87i_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsQzqDs5sDrJl4LvkgqKa8VkfJNpLNAUOJaRD5o3JDsSCO9QPl-2FcgvJYl-2Bv9Qzr7-2FkKWLGObaKEqMjPP6jJnW6ukiESO-2BqRN0Ytc1O1AfKaVRBadiLvOkjcbqkiJ1fMLhuoJCgdvwrxjEOGkbY80S-2Faw-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/63ed82d47d34955e9288aab3/original.png?1676509908" width="48" height="48" border="0" alt="Lumosity"></a>
</td>
<td class="m-hide" width="40"></td>
<td class="m-hide" align="right">
<!-- Socials - Visible for Desktop Only -->
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6uDUiWe9PRIAimvDgZ4AG32-2F1CUt5t8MZ6ncqVne3YkMGeNA_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsjMb-2Btpf43Hi7uzIoeDJyN05-2FISHHMnnGMElENTGt8T1NKHEHcBzOyTAIm2bsE7qFnNJENBjyUlCjcWYQoMF1OPBxxL5wy1-2BF6tTKVTOHW8RIJnH-2B06x-2FCPxCyLq1gkARfecev7Thggvb9oAthQ0H8w-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865c571866d3562619a1b/original.png?1681417669" width="24" height="24" border="0" alt=""></a>
</td>
<td width="24"></td>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6kUwa1-2BmJFBBsz7wzLr6xHwoYYM-2FnncSPISCvdFm1SI7IEyt_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsBVDti6ws-2Fet3CMFGntkCWdqt5y7ZK1b-2BhW3RAsjT0Tl0BqHyRGeU94g1lEhSvc90WKVCkXTUvn3VjAV75WppO1zmyn0K9UzGw3YfNJOT0OLCFIw4wy5YpY2FDpzrnNI40CVtZvTYAhm85wht5q63Hg-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865a94ff8680b877502c1/original.png?1681417641" width="24" height="24" border="0" alt=""></a>
</td>
<td width="24"></td>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6rYHcU3RCY-2BLxbB1ABOqfY-2FTQHG7IGmM7TmSGgHETNt-2FXNF8_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizs7wKKaZTKIbzk8uXuGXZnPcxu9SiXumknZnpcihPXnFXkbt0QxDQ-2BWTBzzBC2IITeD4CjmXL4YAOajRUlFiw0adGEbngGVb3Krxg9A-2BgRrRT9rd1nJXJvYrWTye2F2lFmRu1m82YbFozO7PE9M36c6w-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865852f59462850e6391e/original.png?1681417605" width="24" height="24" border="0" alt=""></a>
</td>
</tr>
</table>
<!-- END Socials - Visible for Desktop Only -->
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td class="py-30" style="border-top: 1px solid #f5f2f0; padding-top: 30px; padding-bottom: 30px;" align="center">
<table border="0" cellspacing="0" cellpadding="0" class="mw-100p">
<tr>
<td class="column text-12 a-center ms-900" style="padding:0; margin:0; font-size:12px; line-height:16px; color:#0e2337; font-weight:500; text-align:center; font-family:'Museo Sans 900', 'Trebuchet MS',sans-serif;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ-2Fpz1McSU2uo4vE89DWkpRZ89F5WphUBXRr8CqzGNxbiezptkIc0GtKa9BY4DPz1sPwbKEuqZvoSPW13DNW2EErlDwkGCAA5XNk1ciSOgz6Rw-3D-3D8sCU_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsyS1NYJgQ5IZWGOGk2S-2FCVyefGwqBNpCyJlL9pwFSoZFok-2B9BD4QG3UAoZUuBF2AQWmnd98xVfdY5WQ-2BaJj9xyUtI9JmvmqxmextGoJrD8Yy47iQd2ftKihSxO43mUjEBdA3uTE3YrTNCiOLHj6l7SQ-3D-3D" target="_blank" class="link" style="color:#0e2337; text-decoration:none;">
<span class="link" style="color:#0e2337; text-decoration:none;">About</span>
</a>
</td>
<td class="column mpb-30" width="95" style="font-size:0pt; line-height:0pt; padding:0; margin:0; font-weight:normal;"></td>
<td class="column text-12 a-center ms-900" style="padding:0; margin:0; font-size:12px; line-height:16px; color:#0e2337; font-weight:500; text-align:center; font-family:'Museo Sans 900', 'Trebuchet MS',sans-serif;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6u2QSZN5g1sm5TyDBmDvO-2Fq-2B6xBVV-2BTh27lMlVMQMtt4rV8k-2B-2F3tAV3mMg3EBuaU9A-3D-3DiuOr_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsFw5dDhyahUJsPvDruKAfxD-2FrUIwMIC52yVtfxLwziOQZcu15-2FdaFwEwQ1MzFbUnHbGtVww6giDfJzzW-2FYMjkEVmr-2FEQ3EL17IZUzDcrXGcWG7vwABArd1mDhSNbZBL8bB23GMeFg5BXjXuTQPjK3HA-3D-3D" target="_blank" class="link" style="color:#0e2337; text-decoration:none;">
<span class="link" style="color:#0e2337; text-decoration:none;">Help</span>
</a>
</td>
<td class="column mpb-30" width="95" style="font-size:0pt; line-height:0pt; padding:0; margin:0; font-weight:normal;"></td>
<td class="column text-12 a-center ms-900" style="padding:0; margin:0; font-size:12px; line-height:16px; color:#0e2337; font-weight:500; text-align:center; font-family:'Museo Sans 900', 'Trebuchet MS',sans-serif;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ-2BliB-2B2c15Z1aqyHa5o2LUJQIBnLQ5kkR5EH-2B1nEOrSYQlPBBVwPfcf-2BpE7McV85aK6Sw6lx36yCpOi7qXnD3ji4l2AzJ9hvpCOHE0tRkTN0vi1ZvgKO9jYVHvwnWubE2M-3DECv2_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsNdt0zybGCNJ1iZM7rX5MpJ3Ytimc4Z3l1EkhFlFVIS2GpP3epudLw9nkQ60ob-2BR2-2FWAhUYnyynNP5Kc0Rm2N5U-2FfVP2wTMPpjwAUq4R83Auh8Fg9Pvkj36MOYdgIa2KbB36TCxMn8Tg37K-2BZ1yZAcQ-3D-3D" target="_blank" class="link" style="color:#0e2337; text-decoration:none;">
<span class="link" style="color:#0e2337; text-decoration:none;">Legal</span>
</a>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td class="py-30 px-60 mpx-24 mmpx-16" style="border-top: 1px solid #f5f2f0; padding-top: 30px; padding-bottom: 30px; padding-left: 60px; padding-right: 60px;">
<!-- Socials - Visible for Mobile only -->
<!--[if !mso]><!-->
<div class="hide-for-desktop" style="font-size:0pt; line-height:0pt; display:none; max-height:0; max-width:0; visibility:hidden; opacity:0; mso-hide:all; overflow:hidden; width:0; height:0;">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="pb-30" align="center" style="padding-bottom: 30px;">
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6uDUiWe9PRIAimvDgZ4AG32-2F1CUt5t8MZ6ncqVne3YkMhxe7_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsrTT4zyzTcCJ6qhnpocuHiO6-2BFty9tAe51OHnJWweFjER2HapVKprQ7UseMy45S1cTIrLhs613iw-2BCN-2BiY-2Br966pU5wDHV9RODnSax5VaZOgu6EEovJQAUzAf7tTnC5Fy7UAY0r-2BArCjG1X2rIlQ5Zg-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865c571866d3562619a1b/original.png?1681417669" width="24" height="24" border="0" alt=""></a>
</td>
<td width="24"></td>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6kUwa1-2BmJFBBsz7wzLr6xHwoYYM-2FnncSPISCvdFm1SI72Ezn_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizswfoApk4lwacey0V8MhOAGS07a8XKXalLSq-2BuvepeV7-2FhU5EtC8UUa8GYjzDs9fmoCtzLh9HIofz7UOryXgW5uxAlmmJS0tTx0lf5QG8HaJc3qPXogN8mLb-2F-2BKB57aUyPu8RGUafoLCMb9hMNMsKkNw-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865a94ff8680b877502c1/original.png?1681417641" width="24" height="24" border="0" alt=""></a>
</td>
<td width="24"></td>
<td class="img" style="font-size:0pt; line-height:0pt; text-align:left;">
<a href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6rYHcU3RCY-2BLxbB1ABOqfY-2FTQHG7IGmM7TmSGgHETNt-2FUadM_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizs-2BI7lNWTz4sxEddMmcJgZryecO6GlEivAl761ePyeR-2BZ8Qe1gD-2Bnkb78LP7lYeHs7TP2pRmXKAWeOajh28y0RlNczoEe9SotoSLWPjcYiO4yXgYrC9B-2Fpx4n7aY9cbsdJBTcsIUCHGkv8MLcUQa7g5g-3D-3D" target="_blank"><img src="https://braze-images.com/appboy/communication/assets/image_assets/images/643865852f59462850e6391e/original.png?1681417605" width="24" height="24" border="0" alt=""></a>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
<!--<![endif]-->
<!-- END Socials - Visible for Mobile only -->
<div class="text-12 lh-20 mlh-18 a-center" style="font-size:12px; color:#0e2337; font-family:'Museo Sans 300',Trebuchet MS,sans-serif; font-weight:500; line-height:20px; text-align:center;"> <a target="_blank" class="link-u" style="color:#0e2337; text-decoration:underline;" href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6o5f2Me08hdgR8aEbhSOcZ8XZSbgjoIjY-2By-2F-2B6U5-2FXYDo2b1AIA1wY7Ca-2FhKPS3n3oCAH5-2F99C0mtDVD7fidT76K6XizTgytQOER1GCy3CDnh-2F-2B05tIfkugdovGQlNiHodllAidx8EiW55RIwJq-2B6ZFMpv-2BSR-2Fxlo8GnOmXq8yaqeYiVd7scjF-2BetFSOrcW-2B7Vb6tA4iQcnpLSVFcMewiHL1uzQ0b4nuwDWXzd2wS4eFQo-2Fe3umdKBY1Qdo5WEE4fFKpdMkvvnqpEBgvTbjE964yYKmSQkuRgMftMsGBO7p7P0BG_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizsK6kE-2FpPsZk63w7-2Fj3K9e7Y-2B1UzfmEtJLnpBflr-2F0ME9QAMXoMgA7zGHzvsqJ58oVK1EISwI2rZQ4-2BzsCOPEwwBXCG1sNtCzPZB3G4fJq87gRb-2BxvXOU-2Fs6eT8WTGT0frO1RGj8CT6P3EyWj1jFBV4w-3D-3D">Update</a> preferences for [email protected] or <a target="_blank" class="link-u" style="color:#0e2337; text-decoration:underline;" href="https://links.notifications.lumosity.com/ls/click?upn=u001.86X-2FBN-2BW8452X5Yl0zWC6mcijAqjvcyx6liKorHQ8a-2FXbZ9wKxllOMk2N7dqrtpaRB8iAz-2B5pTNo67u13u-2B3k46YT9MDRvgqevIbdJ909O3vG0BlyJf6a7MaNrKfmet-2BZ7CCBmB8GP83zKIO3xajU9FAvhtfqlXwR21NCo3YERoMUs0xvSSQxadE-2FHSKEWaOdgYbvi2H1iRiZKtxYGalLPHrisCUSEawZHmpA86OOTq53W7vLjcP3j0-2FvV228qO44is9AJNm2ZfJ0CIMpOelBi5hRtVBHgKt0g84FhPUexENAriKrJ3AUbM-2FngGwg30dPg4pA-2B3VHUumJSiQmFKtWiQqdahGdI1bRP2M052NioK7v67sGnhDBErGU1nPHIUnr8xf-2BIO6VwXqjQ9Kc8umhGFJBizrYFyQ7vM0tXqGGZY3SN-2FJj7VSz-2F9zMc9gu9EvU7pDZOr4PNLrgF5i-2FLigYeY8CPxy8QxwlNwQiL7NVFR2jmHBSIG-2FitKZkIAzciYJ-2BermiZiCiY-2BLJf2QCht2i0uCpzrv3-2FvwzKZfBNpP8YxiE8JvYEJh0-2B63XLXgyi1NcI4u9MDtlxSREbiaNdjRdTtSQ1xX-2Fr0LsljaUIeTsJSSeejljYmxi-2FPOi2Pj7hac4YKdYKU5B79picYpkkY-2BYhoX9YENHY-2FFnlvOt0Qwjnmy-2Fb8-2BiYOW768b2-2Fgl-2BlnzC7yf_HK4ALg3t2TwANFP610Eo0ZDVxli5iSq1sJxcBBEAxwekp3ugyAtZ-2FYzn-2BKiihFrCrif8IEB3fI0kLaAVYF7IfA8TZXBds5XRIJljYT4bEnu-2BVMbNLrR6-2FwkuNnAnF2XxafL9M8XCN9mKulh2bZnVU3qCx3vkhZXrqV6Q-2Fq5MJpav-2BXeHCvzbug9jn3WEsfS362MMGQJkXb-2Fhpxtf9qoj4yAwUp1rouN4jD4RZqK6f8A3spS2BqVQY65ASsB2Bdg89nfN01CcvVKBLLNat7mUlFDFMkNBmXWVfYG3ZDcxSltx-2Fb-2BRikhW-2F-2BSVtAC6-2FVVEveP17xCGEaXuKKLt2o95tNpqPtULoYUlPIBqXIiTOTBt7D9g8IQv41hLGToC-2FPvH9KKog0sm-2FJvf9tFNpFgqqh-2BRsvHi3LwCDdsT6aAukaoJkoiv78-2BjIhPE-2BQ0WpVm6h4J07L6eAZRE8MSQy9OIpXjJjA9creKChgAdFjqmnuQ3cJ90-2BtTzfnTnJAPJAyNBLR13veOF38zg8Hd4NfvaaxUojwcdunjZuMYy7fZMQ2spErpFB1Ta8DDabcuLeHIGC7EcmpFPbFYmQuCPd-2BkgroolfQp2IqkUrbalKvms5pYEVjiW-2FNeX2Z7zSUKJTizshf-2FdkDYjVGnDJrJ1tymYbPJn3mp1PnTWRDg3U5Mj0LO4yD5J-2BtaiQHmmWtRUmOjJmILyVjAF2IKHKWPSq0fwvQSnHwHsEKVhbnwVy-2Bxy8fuWmnoPqMMSYTUYzFTWVC8bXpwhpvIyhsGpggNcKyoktQ-3D-3D"> unsubscribe</a>.
<br><br>
© 2025 Lumos Labs, Inc. | 16 Maiden Lane, Suite 6, San Francisco, CA 94108
</div>
</td>
</tr>
</table>
</td>
</tr>
</div></td></tr></table>
</td></tr></tbody></table></td></tr></tbody></table>
</td></tr></tbody></table>
<!-- End -->
</body>
</html>
Warning
Almost all the messages that arrive here are garbage! Resist the urge to click on any unexpected or questionable links.
It may happen that e-mail will claim to come from liamon.com, especially from some administrative role or process. These are certainly garbage. There are no accounts to expire. There are no passwords to leak. There aren't administrators sending messages to liamon.com addresses. These are certainly phishing attempts.
Absolutely ignore those links!